Sulforaphane suppresses bladder cancer metastasis via blocking actin nucleation-mediated pseudopodia formation.

ARP2/3 complex Bladder cancer Cortactin Glycolysis Pseudopodia WASL

Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
29 Jul 2024
Historique:
received: 14 07 2023
revised: 14 06 2024
accepted: 28 07 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 31 7 2024
Statut: aheadofprint

Résumé

Metastasis is the primary stumbling block to the treatment of bladder cancer (BC). In order to spread, tumor cells must acquire increased migratory and invasive capacity, which is tightly linked with pseudopodia formation. Here, we unravel the effects of sulforaphane (SFN), an isothiocyanate in cruciferous vegetables, on the assembly of pseudopodia and BC metastasis, and its molecular mechanism in the process. Our database analysis revealed that in bladder tumor, the pseudopodia-associated genes CTTN, WASL and ACTR2/ARP2 are upregulated. SFN caused lamellipodia to collapse in BC cells by blocking the CTTN-ARP2 axis. SFN inhibited invadopodia formation and cell invasion by reducing WASL in different invasive BC cell lines. The production of ATP, essential for the assembly of pseudopodia, was significantly increased in bladder tumors and strongly inhibited by SFN. Overexpressing AKT1 reversed the downregulation of ATP in SFN-treated bladder cancer cells and restored filopodia and lamellipodia morphology and function. Bioluminescent imaging showed that SFN suppressed BC metastases to the lung of nude mice by downregulating Cttn and Arp2 expression. Our study reveals the mechanism of SFN action in inhibiting pseudopodia formation, and highlights potential targeting options for the therapy of metastatic bladder cancer.

Identifiants

pubmed: 39084455
pii: S0304-3835(24)00540-8
doi: 10.1016/j.canlet.2024.217145
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217145

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no potential conflicts of interest.

Auteurs

Lei Huang (L)

School of Public Health, Wenzhou Medical University, Wenzhou, 325035, China; Department of Food Science and Nutrition, The Hong Kong Polytechnic University, 999077, Hong Kong Special Administrative Region China.

Jiaxin Wang (J)

School of Public Health, Wenzhou Medical University, Wenzhou, 325035, China.

Xinyi Wang (X)

School of Public Health, Wenzhou Medical University, Wenzhou, 325035, China.

Sicong Zheng (S)

School of Public Health, Wenzhou Medical University, Wenzhou, 325035, China.

Kailin Liang (K)

School of Public Health, Wenzhou Medical University, Wenzhou, 325035, China.

Yea Eun Kang (YE)

Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, 35015, Republic of Korea.

Jae Won Chang (JW)

Department of Otolaryngology-Head and Neck Surgery, Chungnam National University, College of Medicine, Daejeon, 35015, Republic of Korea.

Bon Seok Koo (BS)

Department of Otolaryngology-Head and Neck Surgery, Research Institute for Medical Science, Chungnam National University, School of Medicine, Daejeon, 35015, Republic of Korea.

Lihua Liu (L)

School of Public Health, Wenzhou Medical University, Wenzhou, 325035, China. Electronic address: xjlh92@wmu.edu.cn.

Annamaria Gal (A)

School of Applied Sciences, University of Brighton, Brighton, BN2 4GJ, United Kingdom. Electronic address: A.Gal@brighton.ac.uk.

Yujuan Shan (Y)

School of Public Health, Wenzhou Medical University, Wenzhou, 325035, China; Zhejiang Provincial Key Laboratory of Watershed Sciences and Health, Wenzhou Medical University, Wenzhou, 325035, China. Electronic address: yujuanshan@wmu.edu.cn.

Classifications MeSH